AzTrials
AzTrials

ExerciseNCT03731065

Exogenous Oxidation of Fructose-glucose Mixtures During Running

A study testing Fructose-maltodextrin, Fructose-maltodextrin hydrogel and Glucose-maltodextrin in people with Exercise, run by University of Bath at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to characterise exogenous carbohydrate oxidation rates during exercise, when ingesting glucose (polymers) only, compared to glucose-fructose mixtures, and glucose-fructose mixtures ingested in hydrogel form. Read more about this study

Who is it for?
Ages 18 to 50 years, men onlyHealthy volunteers can take part
Conditions the study is for
Exercise
What is being tested?
Fructose-maltodextrin, Fructose-maltodextrin hydrogel and Glucose-maltodextrin
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteUnited Kingdom
Study dates
14 Oct 2018to 30 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Maximal oxygen consumption > 50 ml.kg-1.min-1
  • > 1 year training in endurance running or triathlon
  • No current injury or injury within the last three months
  • No history of cardiac or metabolic disease such as coronary heart disease or diabetes
  • No current or history of gastrointestinal issues
  • Successful completion of the physical activity readiness questionnaire (PAR-Q)

Who cannot join

  • Female
  • Untrained in endurance running
  • Current injury or injury within the past three months
  • History of cardiac or metabolic disease such as coronary heart disease or diabetes
  • History of or current gastrointestinal issues such as irritable bowel syndrome
  • Unable to replicate diet and training for 3 and 5 days respectively prior to each experimental visit.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Department for Health, University of Bath

    Bath, BA2 7AY

Other trials in United Kingdom

About this study

Official title: Examining Exogenous Carbohydrate Oxidation From Glucose, Multiple Transportable Carbohydrates and Hydrogel Carbohydrate Drinks During Endurance Running

The aim of this study is to characterise exogenous carbohydrate oxidation rates during exercise, when ingesting glucose (polymers) only, compared to glucose-fructose mixtures, and glucose-fructose mixtures ingested in hydrogel form.

Conditions
Exercise
Being tested
Fructose-maltodextrin, Fructose-maltodextrin hydrogel, Glucose-maltodextrin
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fructose-maltodextrinDietary supplement

    Fructose plus maltodextrin in a ratio of 1:1.4, diluted in water to produce a 16% carbohydrate solution.

  • Fructose-maltodextrin hydrogelDietary supplement

    Fructose plus maltodextrin in a ratio of 1:1.4, encapsulated in an alginate-pectin hydrogel diluted in water to produce a 16% carbohydrate solution.

  • Glucose-maltodextrinDietary supplement

    Glucose plus maltodextrin in a ratio of 1:1.4, diluted in water to produce a 16% carbohydrate solution.

Study groups in NCT03731065
Study groupRoleWhat they receive
Fructose-maltodextrin ingestionActive comparatorIngestion of fructose and maltodextrin (glucose polymers) at a rate of 90 g carbohydrate per hour during two hours of treadmill running at 60%VO2peak.
Receives: Dietary Supplement: Fructose-maltodextrin
Fructose-maltodextrin hydrogel ingestionExperimentalIngestion of fructose and maltodextrin (glucose polymers) encapsulated in alginate-pectin hydrogel, drinks at a rate of 90 g carbohydrate per hour during two hours of treadmill running at 60%VO2peak.
Receives: Dietary Supplement: Fructose-maltodextrin hydrogel
Glucose-maltodextrin ingestionActive comparatorIngestion of glucose and maltodextrin (glucose polymers) at a rate of 90 g carbohydrate per hour during two hours of treadmill running at 60%VO2peak.
Receives: Dietary Supplement: Glucose-maltodextrin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak exogenous carbohydrate oxidation rate

    Peak exogenous carbohydrate oxidation rate during 120 min of treadmill running. Measured using isotope ratio mass spectrometry and reported in grams per minute

    Measured: 120 minutes

Secondary outcomes (11)
  1. Total carbohydrate oxidation

    Total carbohydrate oxidation during 120 min of treadmill running. Measured using indirect calorimetry and reported in grams.

    Measured: 120 minutes

  2. Ratings of gastrointestinal discomfort

    Subjective ratings of gastrointestinal discomfort during 120 min of treadmill running. Measured using a 9-item questionnaire on a scale of 1 to 7, where 1 = No discomfort at all and 7 = very severe discomfort.

    Items: Stomach; Heartburn; Acid reflux; Nausea; Rumbling; Bloated; Burping; Passing gas; Bowel movement.

    Measured: 120 minutes

  3. Total fat oxidation

    Total fat oxidation during 120 min of treadmill running. Measured using indirect calorimetry and reported in grams.

    Measured: 120 minutes

  4. Plasma insulin concentrations

    Plasma insulin concentrations during 120 min of treadmill running. Measured using enzyme-linked immunosorbent assay and reported in pmol/L.

    Measured: 120 minutes

  5. Plasma glucose concentrations

    Plasma lactate concentrations during 120 min of treadmill running. Measured using colourimetric assay and reported in mmol/L.

    Measured: 120 minutes

  6. Plasma lactate concentrations

    Plasma lactate concentrations during 120 min of treadmill running. Measured using colourimetric assay and reported in mmol/L.

    Measured: 120 minutes

  7. Plasma non-esterified fatty acid concentrations

    Plasma insulin concentrations during 120 min of treadmill running. Measured using colourimetric assay and reported in umol/L.

    Measured: 120 minutes

  8. Ratings of perceived exertion

    Subjective ratings of perceived exertion using the Borg scale (1982) during 120 min of treadmill running. Measured on a scale of 6 to 20, where 6 = no exertion at all, and 20 = maximal exertion.

    Measured: 120 minutes

  9. Heart rate

    Heart rate during treadmill running measured by telemetry and reported in beats per minute.

    Measured: 120 minutes

  10. Rate of oxygen consumption

    Rate of oxygen consumption during 120 min of treadmill running. Measured using indirect calorimetry and reported in litres per minute.

    Measured: 120 minutes

  11. Rate of carbon dioxide production

    Rate of carbon dioxide production during 120 min of treadmill running. Measured using indirect calorimetry and reported in litres per minute.

    Measured: 120 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2018
  2. Study start14 Oct 2018
  3. Primary completion30 Oct 2019
  4. Study completion30 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03731065
Sponsor's protocol ID
MSES 17/18-001
Status last verified
Dec 2019
First submitted
2 Nov 2018
Last updated
10 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Fructose-maltodextrin, Fructose-maltodextrin hydrogel and Glucose-maltodextrin in people with Exercise, run by University of Bath at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak exogenous carbohydrate oxidation rate (time frame: 120 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in